throbber
UNITED STATES PATENT AND TRADEMARK OFFICE
`
`_______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`_____________
`
`WATSON LABORATORIES, INC.
`Petitioner
`
`v.
`
`UNITED THERAPEUTICS CORP.
`Patent Owner
`_______________
`
`Patent No. 9,358,240

`Issue Date: June 7, 2016

`Title: TREPROSTINIL ADMINISTRATION BY INHALATION
`_______________
`
`Inter Partes Review No. 2017-01621
`__________________________________________________
`
`
`
`PATENT OWNER REPLY TO PETITIONER’S RESPONSE TO
`REQUEST FOR REHEARING UNDER 37 C.F.R. § 42.71
`
`4830-1547-0430.4
`
`

`

`IPR2017-01621
`
`PO Reply to Response to Request for Rehearing
`
`TABLE OF CONTENTS
`
`
`
`I. INTRODUCTION ..................................................................................................................... 1
`
`II. ARGUMENT ............................................................................................................................ 1
`
`A.
`
`B.
`
`Petitioner cannot manufacture a genuine issue of material fact with
`speculation ............................................................................................................. 1
`
`There is no legal requirement to analyze inventorship in order to
`disqualify Ghofrani as prior at “by another.” ................................................... 4
`
`III. CONCLUSION ....................................................................................................................... 5
`
`
`
`
`
`
`
`4830-1547-0430.4
`
`
`
`i
`
`

`

`IPR2017-01621
`
`PO Reply to Response to Request for Rehearing
`
`TABLE OF AUTHORITIES
`
`
`
`Cases
`
`Applied Materials Inc. v. Gemini Research Corp.,
`835 F.2d 279 (Fed. Cir. 1987) .............................................................................. 5
`
`Emerachem Holdings, LLC v. Volkswagen Group of America, Inc.,
`859 F.3d 1341 (Fed. Cir. 2017) ........................................................................2, 3
`
`Ex parte Kroger,
`Appeal No. 442-62 (BPAI November 22, 1982) .................................................. 4
`
`In re Katz,
`687 F.2d 450 (CCPA 1982) .............................................................................1, 4
`
`Nelson Prods., Inc. v. Bal Seal Eng’g, Inc.,
`IPR2014-00573 (PTAB September 29, 2014) ..................................................3, 4
`
`Varian Med. Systs. v. Wm. Beaumont Hosp.,
`IPR2016-00163 (PTAB May 4, 2017) ..............................................................3, 5
`
`
`
`Regulations
`
`37 C.F.R § 42.108(c) .................................................................................................. 2
`
`4830-1547-0430.4
`
`ii
`
`

`

`IPR2017-01621
`
`I. INTRODUCTION
`
`PO Reply to Response to Request for Rehearing
`
`The Patent Trial and Appeal Board’s conclusion that Ghofrani was the work
`
`of another (Decision, 14) was premised on an incorrect legal standard. Petitioner’s
`
`speculation and inapposite authority do not remedy this error.
`
`II. ARGUMENT
`A. Petitioner cannot manufacture a genuine issue of material fact with
`speculation
`
`Patent Owner filed four sworn declarations from Ghofrani authors, both a
`
`named inventor and other authors, showing that Ghofrani is not prior art. Yet
`
`Petitioner argues that the authorship of a separate reference, Voswinckel,
`
`“contradict[s]” the declarations. Response, 4,6. Thus, Petitioner is arguing—
`
`based entirely on its own speculation about Voswinckel—that the four sworn
`
`declarations are untrue.
`
`Petitioner’s speculation that Voswinckel’s authorship is inconsistent with
`
`Ghofrani’s cannot create a genuine issue of material fact as a matter of law. In re
`
`Katz, 687 F.2d 450, 455 (CCPA 1982) (“[J]oint inventorship cannot be inferred in
`
`the face of sworn statements to the contrary”). First, Ghofrani contains material
`
`concededly absent from Voswinckel, which makes Voswinckel’s authorship of
`
`little to no value in evaluating Ghofrani’s authorship. See, e.g., Petition, 29.
`
`Second, even if Petitioner has raised a peripheral question about the naming of
`
`authors on Voswinckel, that does not contradict the authors’ testimony about who
`
`4830-1547-0430.4
`
`1
`
`

`

`IPR2017-01621
`
`PO Reply to Response to Request for Rehearing
`
`“contributed” the relevant subject matter of Ghofrani. Ex. 2020, ¶ 7 (this material
`
`“was contributed” by Voswinckel and Seeger); Ex. 2026 at ¶ 5, Ex. 2027 at ¶ 5,
`
`and Ex. 2028 at ¶ 5 (Ghofrani, Reichenberger, and Grimminger “did not
`
`contribute” to this material). At best, Petitioner has raised a question about why
`
`certain authors were included on Voswinckel, but Petitioner has not presented a
`
`sufficient basis to dispute Patent Owner’s corroborated testimony about who
`
`contributed the relevant portion of Ghofrani. Thus, the Board was not obliged by
`
`37 C.F.R. § 42.108(c) to resolve this issue in favor of Petitioner.
`
`Furthermore, the Seeger Declaration directly addressed Petitioner’s
`
`speculation and establishes that the determination of authorship in Voswinckel is
`
`not a determination of inventorship. Ex. 2020, ¶¶10-11. Contrary to Petitioner’s
`
`assertion (Response, 5-6), the Board’s institution decision provides no indication
`
`that the Board considered this portion of the Seeger Declaration in view of
`
`Petitioner’s arguments.
`
`Petitioner relies on Emerachem Holdings, LLC v. Volkswagen Group of
`
`America, Inc., 859 F.3d 1341 (Fed. Cir. 2017), for the proposition that the four
`
`declarations are insufficient to disqualify Ghofrani as prior art because Emerachem
`
`supposedly requires contemporaneous documentary evidence to support the
`
`testimony of an interested party (i.e., the inventor). Response, 4-5. But
`
`Emerachem did not require contemporaneous documentary evidence. In
`
`4830-1547-0430.4
`
`2
`
`

`

`IPR2017-01621
`
`PO Reply to Response to Request for Rehearing
`
`Emerachem, the uncorroborated testimony of a single inventor co-author was
`
`insufficient to disqualify a reference listing other non-inventor co-authors as prior
`
`art “by another.” Id at 1345-46. In fact, Emerachem mentioned at least one other
`
`alternative to contemporaneous documentary evidence to corroborate such
`
`testimony: testimony from the non-inventor co-authors of the cited reference. Id.
`
`(“Mr. Campbell did not call Mr. Danzinger or Ms. Padron as witnesses or produce
`
`any contemporaneous documentary evidence in support of the Campbell
`
`Declaration.”). Here, Patent Owner has provided both testimony from an inventor
`
`co-author and corroborating testimony from multiple non-inventor co-authors.
`
`Thus, the record evidence is more than sufficient to disqualify Ghofani as prior art
`
`“by another.”
`
`The institution decisions in Varian Med. Systs. v. Wm. Beaumont Hosp. and
`
`Nelson Prods., Inc. v. Bal Seal Eng’g, Inc. are likewise distinguishable. Response,
`
`10; IPR2016-00163, Paper 14 (PTAB May 4, 2017); IPR2014-00573, Paper 9
`
`(PTAB September 29, 2014). At the institution stage of Varian, no declaration
`
`testimony was submitted to disqualify the prior art as “by another.” Varian, Papers
`
`11 and 14. Here, four declarations were provided to support disqualification of
`
`Ghofrani as prior art “by another.” In Nelson, the sole declaration was neither
`
`corroborated nor unequivocal regarding the relevant authors’ contributions.
`
`Nelson, Paper 9, 10-11 (“Mr. Poon indicates that the subject matter of Figures 1-
`
`4830-1547-0430.4
`
`3
`
`

`

`IPR2017-01621
`
`PO Reply to Response to Request for Rehearing
`
`10 may have involved contribution from both co-inventors [of the alleged prior
`
`art]” and “Patent Owner offered the Poon Declaration, but nothing further, and
`
`notably, no declaration by [the inventor on both the prior art and the patent at
`
`issue].”) Here, the statements are both corroborated and unequivocal.
`
`Petitioner’s citation of Ex parte Kroger does not contradict this conclusion.
`
`Appeal No. 442-62 (BPAI November 22, 1982); Response, 5. The Board in
`
`Varian clarified that Ex Parte Kroger “does not stand for the proposition that
`
`declarations from only a subset of named inventors is per se insufficient to satisfy
`
`Katz.” Paper 79, 28. Rather, “the issue in Ex Parte Kroger was that a co-author of
`
`the publication being relied upon as prior art refused to agree that he was not a co-
`
`inventor.” Id. No such disagreement is evidenced by the testimony presented by
`
`Patent Owner. Rather, the statements of the four Ghofrani authors are unequivocal
`
`that the non-inventor co-authors did not contribute to the relevant portion of
`
`Ghofrani and that the material originated with the inventors.
`
`B. There is no legal requirement to analyze inventorship in order to
`disqualify Ghofrani as prior at “by another.”
`
`Petitioner’s remaining arguments (Response, 6-10) rest on the assumption
`
`that “the inventive entity of Ghofrani is Seeger, Voswinckel, Ghofrani,
`
`Grimminger and Richenberg [sic.].” Response, 7. As explained above and in the
`
`Request for Rehearing, the four sworn statements from the Ghofrani authors
`
`explicitly contradict this assumption and suffice to remove the non-inventor co-
`
`4830-1547-0430.4
`
`4
`
`

`

`IPR2017-01621
`
`PO Reply to Response to Request for Rehearing
`
`authors as authors of the relevant portion of Ghofrani. Supra II.A.; Request for
`
`Rehearing, 2-11. Petitioner offers no alternative “inventive entity” other than the
`
`full list of authors on Ghofrani. Petitioner does not comment on whether
`
`additional evidence regarding inventorship should be required if the “inventive
`
`entity” of the relevant portion of Ghofrani was found to exclude the non-inventor
`
`co-authors.
`
`No additional evidence should have been required, and the decision
`
`misapprehends the test in requiring it. Indeed, as the Board held in Varian,
`
`“[u]nlike the inclusion of a non-inventor co-author on a publication, however, the
`
`omission of a named inventor from co-authorship has no significance for whether
`
`the publication is the work of ‘others.’” Varian, Paper 79, 31; Applied Materials
`
`Inc. v. Gemini Research Corp., 835 F.2d 279, 281 (Fed. Cir. 1987). Thus, once
`
`Ghofrani, Grimminger, and Reichenberger disclaimed the relevant portion of
`
`Ghofrani, and Seeger confirmed that it originated with the inventors, the reference
`
`was no longer “by another,” and should have been disqualified as prior art.
`
`III. CONCLUSION
`
`Patent Owner disqualified Ghofrani. Its rehearing request should be granted.
`
`Date: February 28, 2018
`
`4830-1547-0430.4
`
`Respectfully submitted,
`
`/Stephen B. Maebius/
`Stephen B. Maebius
`Registration No. 35,264
`
`
`5
`
`

`

`IPR2017-01621
`
`PO Reply to Response to Request for Rehearing
`
`George E. Quillin
`Registration No. 32,792
`
`Foley & Lardner LLP
`3000 K Street, N.W.
`Suite 600
`Washington, D.C. 20007
`
`Shaun R. Snader
`Registration No. 59,987
`United Therapeutics Corporation
`2nd Fl., 1735 Connecticut Avenue, N.W.
`Washington, DC 20009
`Counsel for Patent Owner
`
`4830-1547-0430.4
`
`6
`
`

`

`IPR2017-01621
`
`
`PO Reply to Response to Request for Rehearing
`
`CERTIFICATE OF SERVICE
`
`The undersigned certifies that a copy of the foregoing PATENT OWNER
`REPLY TO PETITIONER’S RESPONSE TO REQUEST FOR REHEARING
`UNDER 37 C.F.R. § 42.71 is being served on February 28, 2018, by filing this
`document through the PTAB E2E System as well as delivering copies via email to
`the following counsel for the Petitioner:
`
`Michael K. Nutter (Reg. No. 44,979)
`WINSTON & STRAWN LLP
`35 W. Wacker Dr.
`Chicago, IL 60601
`Email: mnutter@winston.com
`
`Andrew R. Sommer (Reg. No. 53,932)
`WINSTON & STRAWN LLP
`1700 K Street, N.W.
`Washington, DC 20006-3817
`Email: asommer@winston.com
`
`Kurt A. Mathas
`WINSTON & STRAWN LLP
`35 W. Wacker Dr.
`Chicago, IL 60601
`Email: kmathas@winston.com
`
`/Stephen B. Maebius/
`
`Stephen B. Maebius
`Registration No. 35,264
`
`George E. Quillin
`Registration No. 32,792
`
`Shaun R. Snader
`Registration No. 59,987
`
`Counsel for Patent Owner
`
`
`
`4830-1547-0430.4
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket